Zobrazeno 1 - 9
of 9
pro vyhledávání: '"туберкулез с множественной лекарственной устойчивостью возбудителя"'
Autor:
Sergey A. Sterlikov, Anastasiya G. Samoylova, Vadim V. Testov, Konstantin A. Glebov, Irina A. Vasilyeva
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 11, Pp 28-33 (2018)
The article presents the comparative assessment of effectiveness of tuberculosis treatment with empiric chemotherapy regimen IV. The outcomes of treatment with empiric regimen IV of the cases in whom later drug resistance was confirmed were compared
Externí odkaz:
https://doaj.org/article/1b51d7e4e14644c0bc49205bcab2cac3
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 9, Pp 31-37 (2018)
The article presents the analysis of multiple drug resistant tuberculosis (MDR TB) prevalence among new and previously treated cases in the Kyrgyz Republic in 2016. The part of MDR TB among new cases makes 21.9%, among relapses – 49.2%, and among p
Externí odkaz:
https://doaj.org/article/6c1bcf35b0db47e78bc1656f3ce99bb0
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 7, Pp 25-32 (2018)
Human immunodeficiency virus (HIV) and tuberculosis with multiple drug resistance (MDR TB) are becoming the major problem for national tuberculosis control programs. Conclusions made by various studies investigating the association of HIV infection a
Externí odkaz:
https://doaj.org/article/2b2a8dca8d654c278cb05b4ee10a35c2
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 5, Pp 36-41 (2018)
The article presents the analysis of outcomes of short course treatment of tuberculosis patients with multiple drug resistance (MDR TB), which was twice shorter compared to standard treatment (9-12 months versus 20-14 months). The efficiency of short
Externí odkaz:
https://doaj.org/article/432a618f29f940cab333ff264021897e
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 1, Pp 11-17 (2018)
The article presents a comprehensive description of tuberculous infection nidi, where children were exposed to this infection and developed multiple drug resistant tuberculosis. It was found out that the risk to develop MDR TB in children was also re
Externí odkaz:
https://doaj.org/article/b94f4317d8564aadb803a113775ef6d4
Autor:
O. V. LOVАCHEVА, M. A. BАGIROV, T. R. BАGDАSАRYAN, E. V. KRАSNIKOVА, E. A. SHERGINА, I. Yu. GRITSАY
Publikováno v:
Туберкулез и болезни лёгких, Vol 95, Iss 9, Pp 60-67 (2017)
The clinical case demonstrates the cure of pulmonary tuberculosis with multiple drug resistance and massive bilateral cavities in a female patient of 31 years old with a severe disorder of pulmonary ventilation of the mixed type, hypoxemic respirator
Externí odkaz:
https://doaj.org/article/de5c211b70614a7b84150e2ae8cfbf46
Autor:
G. S. BALASANYANTS
Publikováno v:
Туберкулез и болезни лёгких, Vol 95, Iss 9, Pp 49-54 (2017)
The goal of the study: to evaluate efficiency and safety of the anti-tuberculosis drug of bedaquiline in the multimodality therapy of patients with HIV-associated tuberculosis with multiple/extensive drug resistance (MDR/XDR).Materials and methods. 1
Externí odkaz:
https://doaj.org/article/f2620ac4fbdb4b7ab4719e8871fe79fd
Publikováno v:
Туберкулез и болезни лёгких, Vol 0, Iss 11, Pp 10-15 (2015)
The article presents the comparative description of multiple resistant tuberculosis patients (MDR TB) abusing alcohol (group 1 – 169 people), and not abusing alcohol (group 2 – 122 persons); the frequency and specificity of adverse reaction to an
Externí odkaz:
https://doaj.org/article/3939f4a517294b0cb2913b4568dc8af6
Autor:
Ya. R. Batyrshina, T. I. Petrenko
Publikováno v:
Туберкулез и болезни лёгких, Vol 0, Iss 5, Pp 26-35 (2014)
A retrospective cohort study was performed to reveal risk factors for fluoroquinolone resistance in M. tuberculosis during treatment of 463 patients with multidrug-resistant (MDR) tuberculosis (TB) in the Novosibirsk Region. The factors associated wi
Externí odkaz:
https://doaj.org/article/bc0d04fd5adb401f8c19cb3babf370dc